![]() |
市場調查報告書
商品編碼
2128548
鯊烯市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測Squalene Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球鯊烯市場在2025年達到1.8503億美元,預計2026年成長至2.0291億美元,2034年達到4.3736億美元,預測期內CAGR為10.10%。2025年,歐洲將以48.00%的市場佔有率引領全球市場,這主要得益於化妝品、製藥和個人護理行業的強勁需求。
角鯊烯是一種天然存在的有機化合物,傳統上是從鯊魚肝油中提取的。然而,出於永續性的考慮,橄欖油、莧菜籽、小麥胚芽和甘蔗等植物來源的角鯊烯正變得越來越受歡迎。由於其卓越的保濕和抗氧化特性,角鯊烯廣泛用於護膚產品中。它在藥物製劑中也發揮著重要作用,尤其是在疫苗中作為佐劑,並且是眾多行業的關鍵成分。
由於消費者對天然和植物來源成分的偏好日益成長、對藥物研發投入的增加以及對永續化妝品配方的意識不斷提高,市場穩步擴張。此外,製造商使用生物技術衍生的角鯊烯,以減少對海洋資源的依賴,同時滿足監管和環境標準。
市場趨勢
影響角鯊烯市場的最重要趨勢之一是消費者對植物來源和永續來源角鯊烯的需求不斷成長。消費者越來越意識到鯊魚來源成分所帶來的環境問題,並積極選擇由橄欖、甘蔗和莧菜等再生植物資源製成的護膚產品。
此外,化妝品行業越來越重視「潔淨標示」和「零殘忍」配方,敦促製造商用永續的替代品取代傳統的動物性成分。同時,生技公司生產發酵角鯊烯,這種角鯊烯在醫藥和化妝品應用領域實現了品質穩定和擴充性的提升。
市場促進因素
全球護膚和化妝品行業的快速擴張仍然是該市場最強勁的成長要素之一。角鯊烯因其卓越的保濕功效、增強皮膚彈性和促進活性成分吸收的能力,成為保濕霜、抗衰老面霜、精華液和防曬油等產品中的重要成分。可支配收入的成長、美容意識的提高以及消費者對高階護膚品日益成長的偏好,持續支撐著市場需求。
另一個主要促進因素是角鯊烯在製藥領域的應用日益廣泛。角鯊烯廣泛用作疫苗佐劑,以增強免疫反應並提高疫苗效力。疫苗產量的增加以及對先進藥物遞送系統的持續研究,創造製藥廠商的強勁需求。此外,對角鯊烯新治療應用的研究預計將在預測期內創造更多機會。
市場限制因素
儘管需求不斷成長,但由於鯊魚角鯊烯相關的環境問題,市場面臨挑戰。過度捕撈鯊魚導致永續性和生物多樣性問題,促使相關法規更加嚴格,並迫使製造商採用替代原料。
此外,植物來源或透過生物技術生產的鯊烯通常製造成本很高,這給製造商在保持產品品質和盈利的同時進行定價帶來了挑戰。
市場機會
向永續原料的轉型為行業相關人員帶來了巨大的成長機會。隨著全球法規日益重視環保採購,投資於生物技術衍生和植物來源鯊烯生產的企業有望獲得競爭優勢。
隨著在營養補充品、機能性食品、藥品和高階化妝品等領域的應用不斷擴大,預計未來幾年市場機會將進一步成長。
依原料
從原料的角度來看,市場區隔將其分為三類:動物性、植物來源、生物合成性。
動物性成分已在化妝品和藥品配方中應用多年,預計到2026年將佔據全球市場55.42%的佔有率。然而,隨著製造商加速轉向永續的、未經動物測試的成分,植物來源成分預計將在預測期內實現最快成長。
依最終用途行業分類
從終端用戶產業來看,市場細分將產品分為化妝品、藥品、食品和其他類別。
預計到2026年,化妝品領域將佔據最大佔有率,佔全球市場的70.51%。消費者對高階護膚和純淨美妝產品的需求不斷成長,並持續推動產品的普及。同時,製藥領域也呈現強勁成長動力,這主要得益於鯊烯在疫苗佐劑中的應用日益廣泛以及先進藥物傳輸技術的進步。
到2025年,歐洲市場規模達到8,963萬美元,繼續保持其領先區域市場的地位,並預計到2026年將達到9,798萬美元。該地區受惠於先進的化妝品製造技術、強大的醫藥研發實力以及對永續來源原料的日益普及。
2025年北美市場規模為4,390萬美元,預計到2026年將達到4,785萬美元,主要得益於對護膚品的強勁需求和醫藥領域的創新。
亞太地區市場規模在2025年達到 4,121萬美元,在2026年達到 4,498萬美元。製藥業的快速擴張、醫療保健支出的增加以及對高階化妝品需求的成長推動該地區的成長。
到2025年,拉丁美洲的市場規模達到 747萬美元,預計到2026年將成長到 809萬美元,這得益於豐富的植物來源原料和不斷提高的當地生產能力。
到2025年,中東和非洲市場規模達到 374萬美元,預計到2026年將達到 402萬美元,這主要得益於對永續化妝品成分的需求不斷成長以及醫療保健基礎設施的改善。
The global squalene market was valued at USD 185.03 million in 2025 and is projected to grow from USD 202.91 million in 2026 to USD 437.36 million by 2034, exhibiting a CAGR of 10.10% during the forecast period. Europe dominated the global market with a 48.00% market share in 2025, supported by strong demand from the cosmetics, pharmaceutical, and personal care industries.
Squalene is a naturally occurring organic compound traditionally extracted from shark liver oil, although plant-based sources such as olive oil, amaranth seed, wheat germ, and sugarcane are becoming increasingly popular due to sustainability concerns. The ingredient is widely used in skincare products because of its excellent moisturizing and antioxidant properties. It also plays a significant role in pharmaceutical formulations, especially as an adjuvant in vaccines, making it an important ingredient across multiple industries.
The market is witnessing steady expansion due to the rising consumer preference for natural and plant-derived ingredients, increasing investments in pharmaceutical research, and growing awareness of sustainable cosmetic formulations. Manufacturers are also introducing biotechnology-derived squalene to reduce dependence on marine resources while meeting regulatory and environmental standards.
Market Trends
One of the most significant trends shaping the squalene market is the growing demand for plant-based and sustainably sourced squalene. Consumers are becoming increasingly aware of environmental issues associated with shark-derived ingredients and are actively choosing skincare products made from renewable botanical sources such as olives, sugarcane, and amaranth.
The cosmetics industry is also emphasizing clean-label and cruelty-free formulations, encouraging manufacturers to replace conventional animal-derived ingredients with sustainable alternatives. In addition, biotechnology companies are producing fermentation-based squalene, offering consistent quality and improved scalability for pharmaceutical and cosmetic applications.
Market Drivers
The rapid expansion of the global skincare and cosmetics industry remains one of the strongest growth drivers for the market. Squalene provides excellent hydration, improves skin elasticity, and enhances the absorption of active ingredients, making it an essential ingredient in moisturizers, anti-aging creams, serums, and sunscreens. Rising disposable incomes, growing beauty awareness, and increasing preference for premium skincare products continue to support market demand.
Another major driver is the growing pharmaceutical application of squalene. It is widely used as a vaccine adjuvant that strengthens immune responses and improves vaccine effectiveness. The increased production of vaccines and continuous research into advanced drug delivery systems are generating strong demand from pharmaceutical manufacturers. Furthermore, ongoing studies exploring new therapeutic applications of squalene are expected to create additional opportunities during the forecast period.
Market Restraints
Despite its growing demand, the market faces challenges due to environmental concerns associated with shark-derived squalene. Excessive harvesting of sharks has raised sustainability and biodiversity issues, resulting in stricter regulations and increased pressure on manufacturers to adopt alternative raw materials.
Additionally, plant-derived and biotechnology-produced squalene often involve higher production costs, creating pricing challenges for manufacturers while maintaining product quality and profitability.
Market Opportunities
The transition toward sustainable ingredients presents significant growth opportunities for industry participants. Companies investing in biotechnology-derived and plant-based squalene production are expected to gain a competitive advantage as global regulations increasingly favor environmentally responsible sourcing.
Growing applications in nutraceuticals, functional foods, pharmaceuticals, and premium cosmetics are expected to further expand market opportunities over the coming years.
By Source
Based on source, the market is segmented into animal, plant, and biosynthetic.
The animal segment is projected to dominate the global market with a 55.42% share in 2026 due to its long-established use in cosmetics and pharmaceutical formulations. However, the plant segment is expected to register the fastest growth during the forecast period as manufacturers increasingly shift toward sustainable and cruelty-free ingredients.
By End-use Industry
Based on end-use industry, the market is segmented into cosmetics, pharmaceuticals, food, and others.
The cosmetics segment is expected to account for the largest share, contributing 70.51% of the global market in 2026. Rising consumer demand for premium skincare products and clean beauty formulations continues to drive product adoption. Meanwhile, the pharmaceutical segment is witnessing strong growth due to increasing utilization of squalene in vaccine adjuvants and advanced drug delivery technologies.
Europe remained the leading regional market with a value of USD 89.63 million in 2025 and is projected to reach USD 97.98 million in 2026. The region benefits from advanced cosmetic manufacturing, strong pharmaceutical research, and increasing adoption of sustainably sourced ingredients.
North America accounted for USD 43.90 million in 2025 and is expected to reach USD 47.85 million in 2026, driven by robust demand for skincare products and pharmaceutical innovations.
Asia Pacific generated USD 41.21 million in 2025 and is projected to reach USD 44.98 million in 2026. Rapid expansion of pharmaceutical manufacturing, increasing healthcare expenditure, and rising demand for premium cosmetics are supporting regional growth.
Latin America reached USD 7.47 million in 2025 and is expected to grow to USD 8.09 million in 2026, supported by abundant plant-based raw materials and increasing local production capabilities.
The Middle East & Africa market stood at USD 3.74 million in 2025 and is projected to reach USD 4.02 million in 2026, driven by growing demand for sustainable cosmetic ingredients and improving healthcare infrastructure.
Competitive Landscape
The global squalene market is moderately competitive, with leading companies focusing on sustainable sourcing, biotechnology-based production, product innovation, strategic partnerships, and international expansion to strengthen their market positions. Many manufacturers are investing in plant-derived and fermentation-based production technologies to address environmental concerns while meeting rising global demand.
Major companies operating in the market include Amyris, Sophim, Kishimoto Special Liver Oil Co., Ltd., Empresa Figueirrense de Pesca, Matrix Life Science Private Limited, Croda International Plc, Aasha Biochem, and Evonik Healthcare.
Key Industry Developments
Conclusion
The global squalene market is positioned for strong long-term growth, supported by rising demand from cosmetics, pharmaceuticals, and personal care industries. The industry's transition toward sustainable, plant-based, and biotechnology-derived production methods is creating new opportunities for manufacturers while addressing environmental concerns associated with traditional sources. Growing investments in clean beauty products, vaccine development, and advanced healthcare applications are expected to sustain market expansion from USD 202.91 million in 2026 to USD 437.36 million by 2034, making squalene an increasingly important ingredient across multiple high-growth industries.
Segmentation By Source
By End-Use Industry
By Region